Samsung Biologics Offers $1.8 Billion to Acquire PolyPeptide
Samsung Biologics has offered to buy PolyPeptide in an all-cash deal worth approximately $1.8 billion, which translates to $55.17…
-
-
Oral Semaglutide Gains UK Approval, Raising Hopes for Greater Access to GLP-1 Therapy
People dealing with weight management just got a brand-new option. For the first time, health regulators have approved a…
-
GLP-1 Weight Loss Calculator for Mounjaro and Wegovy Users
New GLP-1 medications have changed how doctors treat obesity today. Semaglutide and tirzepatide are the most popular drugs in…
-
GLP-1 Pills and Mounjaro
The arrival of oral GLP-1 receptor agonists marks a major shift in how we manage metabolic disease. Mounjaro, a…
